人纖溶酶原激活物抑製劑 1 定量分析酶聯免疫檢測試劑盒 - ELISA試劑盒 - 細胞凍存液|胎牛血清|細胞株|細胞培養基|ELISA試劑盒|ECL發光液|國產血清|澳洲血清|完全培養基-上海尊龍凱時生物科技有限公司
申請試用裝
人纖溶酶原激活物抑製劑 1 定量分析酶聯免疫檢測試劑盒
貨號 :HME055
價格 :¥0.00
加入購物車 ,提交訂單信息之後 ,尊龍凱時會第一時間與您取得聯係 !
  • 產品信息
  • 產品說明(可下載)
  • 參考文獻
  • 常見問題

上海尊龍凱時生物科技有限公司 www.ruianjituan.com

人纖溶酶原激活物抑製劑 1 定量分析酶聯免疫檢測試劑盒

本試劑盒僅供科研使用。用於體外定量檢測人血清 、血漿或細胞培養上清液中的PAI-1濃度 。使用前請仔細閱讀說明書並檢查試劑組分

是否完整 。如有產品包裝破損或質量投拆 ,請在收到貨一個月之內聯係尊龍凱時 。

PAI-1簡介 :

人纖維蛋白溶酶原激活物抑製劑-1(PAI-1) ,也稱為絲氨酸蛋白酶抑製劑E1(Serpin E1) ,是絲氨酸蛋白酶抑製劑超家族中的一員 。PAI-1

是組織型纖溶酶原激活劑(tissue plasminogen activator ,tPA)和尿激酶纖溶酶原激活劑(urokinase plasminogen activator ,uPA)的主

要抑製劑 ,活化纖溶酶原而引起纖維蛋白溶解 。人的PAI-1是一個378個氨基酸 ,分子量為42.7 kDa的蛋白 。

PAI-1主要由內皮產生 ,當然其它組織類型如脂肪組織的細胞也會分泌 。脂肪組織 、肝及血管等PAI-1的產生明顯 ,當然在某些類型的腫

瘤細胞也有PAI-1分泌 。

PAI-1與組織型纖溶酶原激活劑的快速結合,在纖維蛋白溶解的過程中是非常重要的一個調節點 。PAI-1的濃度,與纖溶酶原激活劑的降

低相關的特點 ,使得血栓症及其它心血管疾病發生的風險增加 。當然 ,PAI-1已被證明在心血管病與肥胖症二者的關聯中起關鍵的作用 。

檢測原理:

本試劑盒采用雙抗體夾心ELISA法檢測樣本中PAI-1的濃度 。PAI-1捕獲抗體已預包被於酶標板上 ,當加入標本或參考品時 ,其中的PAI-1

會與捕獲抗體結合 ,其它遊離的成分通過洗滌的過程被除去。當加入生物素化的抗人PAI-1抗體後 ,抗人PAI-1抗體與PAI-1接合 ,形成夾心

的免疫複合物 ,其它遊離的成分通過洗滌的過程被除去 。隨後加入辣根過氧化物酶標記的親合素 。生物素與親合素特異性結合 ,親合素連

接的酶就會與夾心的免疫複合物連接起來 ;其它遊離的成分通過洗滌的過程被除去 。最後加入顯色劑 ,若樣本中存在PAI-1將會形成免疫複

合物 ,辣根過氧化物酶會催化無色的顯色劑氧化成藍色物質 ,在加入終止液後呈黃色 。通過酶標儀檢測 ,讀其450nm處的OD值 ,PAI-1濃度

OD450值之間呈正比 ,通過參考品繪製標準曲線 ,對照未知樣本中OD值 ,即可算出標本中PAI-1濃度 。

PAI-1定量分析酶聯免疫檢測試劑盒組成:

組分 規格(96T/48T)

PAI-1預包被板 12條/6條

5×標準品稀釋液 20ml/10ml

PAI-1標準品 2/1支(凍幹)

PAI-1生物素化抗體 10ml/5ml

親和素連接的HRP酶 10ml/5ml

濃縮洗滌液 20× 30ml/15ml

TMB底物 10ml/5ml

中止液 5ml/3ml

封板膠紙 3/2張

說明書 1份

標本收集:

1.標本的收集請按下列流程進行操作 ;

A.細胞上清標本離心去除懸浮物後即可 ;

B.血清標本應是自然凝固後 ,取上清 ,避免在冰箱中凝固血液 ;

C.血漿標本 ,推薦用EDTA的方法收集 ,不能使用肝素鈉抗凝劑 ;

D.若待測樣本不能及時檢測 ,標本收集後請分裝 ,凍存於-20℃ ,避免反複凍融 。

2.血清標本不應添加任何防腐劑或抗凝劑 ;

3.標本應清澈透明 ,檢測前樣本中如有懸浮物應通過離心去除 。

4.請勿使用溶血 ,高血脂或汙染的標本檢測 ,否則結果將不準確 。注意事項:

1.試劑盒請保存在2~8℃ 。

2.濃縮洗滌液因在低溫下可能有結晶 ,請水浴加熱使結晶完全溶解後再配製工作液 。

3.標準品複溶加樣後 ,剩餘部份請丟棄 。

4.底物請勿接觸氧化劑和金屬 。

5.加樣時 ,請及時更換槍頭 ,避免交叉汙染 。

6.嚴禁混用不同批號的試劑盒組份 。

7.充分混勻對保證反應結果的準性很重要 ,在加液後請輕輕叩擊邊緣以保證混勻 。

8.室溫反應 ,請嚴格控製在25~28℃ 。

9.洗滌過程是至關重要的 ,洗滌不充分會使精確度下降並導致結果誤差較大 。

10.試驗中標準品和樣本檢測時建議作雙複孔 。

11.加樣過程中避免氣泡的產生 。

12.血清和血漿標本的檢測時 ,檢測抗體的孵育時間應適當延長 。

檢測前準備工作:

1.試劑盒自冰箱中取出後應置室溫(25-28℃)平衡20分鍾 ;每次檢測後剩餘試劑請及時於2~8℃保存 。

2.將濃縮洗滌液用雙蒸水或去離子水稀釋(1份加19份水) 。

3. 5×標準品稀釋液用雙蒸水或去離子水稀釋(1份加4份水) 。

4.標準品: 按標簽複溶體積加入1×標準品稀釋液用複溶使PAI-1終濃度達到20pg/ml ,室溫反應 ,請嚴格控製在2528℃ ,靜置15~20分鍾

後輕輕混懸(建議抽吸幾次)待徹底溶解 ,用標準品稀釋液倍比梯度稀釋後依次加入檢測孔中 。(標準曲線取七個點 ,最高濃度為20pg/ml,

標準品稀釋液直接加入作為0濃度.

洗滌方法:

自動洗板機或人工洗板 :每孔洗滌液為300ul ,注入與吸出間隔15-30秒 。洗板5次 。最後一次洗板完成後將板倒扣著在厚吸水紙上用力拍幹 。

實驗過程需自備的材料 :

1.不同規格的加樣槍及相應的槍頭 ;

2.酶標儀 ;

3.自動洗板機 ;

4.去離子水或雙蒸水 ;

操作步驟:

1.通過計算並確定一次性實驗所需的板條數 ,取出所需板條放置在框架內 ,暫時用不到板條請放回鋁箔袋密封,保存於4℃ 。

2.建議設置本底較正孔 ,即空白孔,設置方法為該孔隻加TMB顯色液和中止液 。每次實驗均需做標準品對照並畫出標準曲線 。

3.分別將標本或不同濃度標準品(100ul/孔)加入相應孔中 ,用封板膠紙封住反應孔 ,室溫(25-28℃)孵育120分鍾 。不同樣本中PAI-1含量

不一樣 ,試劑盒用來檢測血清樣本的稀釋倍數一般1~250倍稀釋 ,如果無明確範圍 ,需提前預實驗 ,如果超出檢測範圍 ,應用標準品稀釋液

稀釋後重新檢測 。細胞上清稀釋倍數一般1~4倍 ,如果超出檢測範圍 ,應用標準品稀釋液稀釋後重新檢測 。

4.洗板5次 ,且最後一次置厚吸水紙上拍幹 。

5.加入生物素化抗體工作液(100ul/孔) 。用封板膠紙封住反應孔 ,室溫(25-28℃)孵育60分鍾 。

6.洗板5次 ,且最後一次置厚吸水紙上拍幹 。

7.加入親和素連接的HRP酶工作液(100ul/孔) 。用封板膠紙封住反應孔 ,避光室溫(25-28℃)孵育20分鍾 。

8.洗板5次 ,且最後一次置厚吸水紙上拍幹 。

9.加入顯色劑TMB100ul/孔 ,避光室溫(25-28℃)孵育20分鍾 。

10.加入中止液50ul/孔,混勻後即刻測量OD450值 。

上海尊龍凱時生物科技有限公司 www.ruianjituan.comPAI-1標準曲線

0

0.5

1

1.5

2

2.5

0 0.625 1.25 2.5 5 1 0 2 0

PAI-1濃度(ng/ml)

O

D值

上海尊龍凱時生物科技有限公司 www.ruianjituan.com

結果判斷:

1.複孔的值在20%的差異範圍內結果才有效 ,複孔的值平均後可作為測量值 。

2.每個標準品或標本的OD值應減去本底校正孔的OD值 。

3.手工繪製標準曲線 。以標準品濃度作橫坐標 ,OD值作縱坐標 ,以平滑線連接各標準品的坐標點 。通過標本的OD值可在標準曲線上查出其

濃度 。

4.若標本 OD 值高於標準曲線上限 ,應適當稀釋後重測 ,計算濃度時應乘以稀釋倍數 。

典型數值和參考曲線

濃度pg/ml 典型OD1 典型OD2 OD平均值

0 0.11 0.098 0.104

0.625 0.275 0.251 0.263

1.25 0.487 0.435 0.461

2.5 0.735 0.671 0.703

5 1.081 1.049 1.065

10 1.567 1.511 1.539

20 2.32 2.112 2.216

PAI-1參考標準曲線

注意 :本圖僅供參考 ,應以同次試驗標準品所繪標準曲線計算標本含量 。

靈敏度 ,特異性和重複性:

1.靈敏度 :多次重複結果表明 ,最小檢出量為112pg/ml 。

2.特異性 :與人的Serpin A1  、Serpin A3  、Serpin A4  、Serpin A5 、Serpin B6  、Serpin B8無交叉反應性 。與小鼠的Serpin E1無交

叉反應性 。

3.重複性 :板內 ,板間變異係數均<10%.

參考文獻:

1. Fay, W.P. et al. (1997) Blood 90:204.

2. Alessi, M.C. and I. Juhan-Vague (2006) Arteriosescler. Thromb. Vasc. Biol. 26:2200.

3. Minor, K.H. et al. (2005) J. Biol. Chem. 280:28711.

4. Tsai, S.J. (2006) Med. Hypotheses 66:319.

5. Duffy, M.J. (2002) Clin. Chem. 48:1194.

6. Cho, S.H. et al. (2004) Exp. Biol. Med. 229:138. 上海尊龍凱時生物科技有限公司 www.ruianjituan.com

ELISA Kit for the Quantitative Analysis of Human PAI-1

The human PAI-1 ELISA (enzyme-linked immunosorbent assay) kit is used for detection of human PAI-1 in cell culture

supernatants,human serum and plasma.THE ELISA KIT IS FOR RESEARCH USE ONLY. Please read this instruction manual carefully

and check out the material provided before use, and you can contact with our company if any questions. You can enter our website or call

us for other aim.

Introduction

Plasminogen Activator Inhibitor 1 (PAI-1), also known as Serpin peptidase inhibitor, clade E (SERPINE1), is a member of the serine

protease inhibitor (serpin) superfamily. PAI-1 is the principal inhibitor of Tissue Plasminogen Activator (tPA) and Urokinase (uPA), the

activators of Plasminogen and hence fibrinolysis. Human PAI-1 is a 42.7 kDa protein containing 379 amino acid residues.

PAI-1 is mainly produced by the endothelium, but is also secreted by other tissue types, such as adipose tissue. PAI-1 is expressed

predominantly in adipose, liver and vascular tissues, but is also produced by certain tumor cells.

PAI-1 rapid interaction with TPA may function as a major control point in the regulation of fibrinolysis. PAI-1 levels, along with the

consequential deficiency in plasminogen activators, can lead directly to increased risk of thrombosis and other coronary diseases.

Accordingly, PAI-1 has been implicated as an important molecular link between obesity and coronary disease.

Principles of the Test

The kits is a solid sandwich enzyme-linked immunosorbent assay for detection of human PAI-1. An anti-human PAI-1 monoclonal

antibody has been absorbed onto the wells of the microtiter strips provided. Samples including specimens or standards were pipetted into

wells. The human PAI-1 in specimens or standards would be captured by the coated antibody and the free others were removed by

washing. The human PAI-1 biotin-conjugated antibody were added and binds to human PAI-1 captured by the first antibody, which

formed a sandwich. Streptavidin-HRP would be added and binds to the biotin conjugated antibody, then free Streptavidin-HRP would be

removed during a wash step. After this, subtrate solution would be added and catalyzed by the HRP, and a coloured product is formed.

The intensity of the colored product is used to calculate in proportion to the amount of human PAI-1 in the original specimen.

Materials provided with the kits:

Reagent 96/48Test Kit

Human PAI-1 Antibody-Coated Wells 12 strips/6 strips

Standard Diluent 20ml/10ml

Human PAI-1 Standard 2/1vial(s)

Human PAI-1 Detetion Antibody 10ml/5ml

Streptavidin-HRP 10ml/5ml

Wash Buffer Concentrate 20× 30ml/15ml

TMB 10ml/5ml

Stop Solution 5ml/3ml

Plate Covers 3/2

Complete Instruction Manual 1

Specimen Collection

1. Collecting specimen as following:

A. The particulate of the cell culture supernatants should be removed before use.

B. Serum was obtained from clot at room temperature.

C. Please collect plasma with EDTA. Heparin plasma is not recommended

D. Assay immediately or store samples at -20. Avoid free-thaw cycles.

2. Antiseptic and anticoagulant should not appear in Serum samples.

3. Any particulate should be removed from samples before use.4. Do not use grossly hemolyzed or lipemic samples.

Precautions for use:

1.Please storage the Kit at 28℃ 。

2. Washing buffer concentrate may have crystal in low temperature, and you can melt its in water-bath before use.

3. Please discard the remains after use of the dissolved standard.

4. Avoid contact of substrate solution with oxidizing agents and metal.

5. Usage of disposable pipette tips avoid microbial contamination or cross-contamination of reagents or specimens.

6. Do not mix or substitute reagents with those from other lots or other sources.

7. To ensure the adequate mixure of added reagents, please tap gently the plate after the wells were filled with liquid.

8. Incubation temperature should be 2528.

9. Wash step was crucial for whole assay process.

10. Duplicate wells of the same sample were recommended in assay process.

11. Avoid the foam while pour the liquid into wells.

12For serum or plasma samples ,the biotin-conjugated antibody should be incubate for at least 90 minutes.

Reagent Preparation

1.The reagents should be warmed up to room temperature before use. The remanent reagents must reseal and put into refrigeratory

again as soon as possible.

2.Dilute 1ml of wash buffer Concentrate into 19ml deionized or distilled water to work.

3. Dilute 1ml of 5×sample diluent into 4ml deionized or distilled water to 1×sample diluent.

4. Add the standard dilution solution to the bottle according to the volume of the label and wait 15 minutes for complete dissolution.

Incubation temperature should be 2528. And in turn add the half concentration diluent by standard diluent .

Wash step:

Automated microplate washer or operating by pipette: Each well should be pour into300ul wash buffer and soak 15 or 30 seconds,then

be aspirated, five times process were repeated. After the last wash, remove remaining wash buffer by aspirating. Invert the plate and blot

it against clean paper towels.

Materials Required But Not Provided

1. pipettes and pipette tips

2. Microwell strip reader capable of reading at 450 nm (540 nm as optional reference wave length)

3. automated microplate washer

4.Glass-distilled or deionized water

Assay procedure

1.The needed strips were putted into the frame, the remains were returned into foil pouch and resealed.

2.Blank well were recommended, which only color reagent and stop solution be added. It is suggested that each testing with gradient

density of standard for standard curve.

3.Add 100ul of standard or sample.Cover with the Plate Covers provided.Incubate for 2 hours at room temperature, Levels of PAI-1 may

vary between different samples. Optimal dilution factors for each sample must be determined by the investigator.

4.Five times wash process were repeated.

5.Add 100ul of detetion antibody. Cover with the Plate Covers provided.Incubate for 1 hour at room temperature.

6.Five times wash process were repeated.

7.Add 100ul of Streptavidin-HRP. Cover with the Plate Covers provided. Lucifugal incubation for 20 minutes at room temperature.

8.Five times wash process were repeated.

9.Add 100ul of TMB ,Lucifugal incubation for 20 minutes at room temperature.

10.Add 50ul of stop solution to each well, determine the optical density of each well within 10 minutes.

Calculation of Results

1. Duplicates should be within 20 percent of the mean. Average absorbance values for each set of duplicate samples were used as

detection results.

2. The blank absorbance values of subtract should be deducted.

3. Drawing a best fit curve through the points of graph. Draw the standard curve by plotting assayed OD valure (on the Y axis) vs.

concentration (on the X axis). The sample concentration was obtained based on its OD value founding in the standard concentration

curve.

4. If the values obtained are not within the expected range of the standard, Samples should be dilute and assay again.

Typical Data and Standard Curve

Concentration(pg/ml) Typical data 1 Typical data 2 Average

0 0.11 0.098 0.104

0.625 0.275 0.251 0.263

1.25 0.487 0.435 0.461

2.5 0.735 0.671 0.703

5 1.081 1.049 1.065

10 1.567 1.511 1.539

20 2.32 2.112 2.216

Human PAI-1 Standard Curve

Sensitivity, Specificity, Repeatability

Sensitivity: repeated assays were evalsuated and the minimum detectable dose was112 pg/ml.

Specificity : No significant cross-reactivity or interference with human Serpin A1 ,Serpin A3 ,Serpin A4 ,Serpin A5 ,Serpin B6 ,Serpin B8

and Mouse Serpin E1.

Repeatability: The coefficient of variation between wells or plates is less than 10 percent.

REFERENCES:

1. Fay, W.P. et al. (1997) Blood 90:204.

2. Alessi, M.C. and I. Juhan-Vague (2006) Arteriosescler. Thromb. Vasc. Biol. 26:2200.

3. Minor, K.H. et al. (2005) J. Biol. Chem. 280:28711.

4. Tsai, S.J. (2006) Med. Hypotheses 66:319.

5. Duffy, M.J. (2002) Clin. Chem. 48:1194.

6. Cho, S.H. et al. (2004) Exp. Biol. Med. 229:138.

 


公司簡介 / Company profile
上海尊龍凱時生物科技有限公司
Shanghai Chuan Qiu Biotechnology Co.,Ltd.
       公司主要依托複旦大學 、同濟大學等上海地區多家著名高校 ,擁有一支富有經驗的開發團隊 ,專業從事細胞及細胞...
聯係尊龍凱時 / Contact
電 話 :021-69950217  173-2144-0983
傳 真 :021-69950218
郵 箱 :2078251929@qq.com
郵 編 :201800
地 址 :上海市嘉定區翔江公路518號寅尚產業園D座210室
Copyright © 2018 CHUANQIU Biotechnology Co.,Ltd. All Rights Reserved. 滬ICP備18030131號-1
  • 申請試用裝
  • 021-69950217